Target-driven machine learning–enabled virtual screening (TAME-VS) enables prioritization of AKR1C3 inhibitors
Longjiang Qiao, Xinyu Li, Shuaishuai Xing, Qianwen Guan, Kun Ning, Weijie Han, Luyu Zhang, Anlan Dai, Weiqi Yang, Yinhang Liu, Jason J Kwon, Xin Gao, Haopeng Sun, Yuemin Bian · 2026
Read Target-driven machine learning–enabled virtual screening (TAME-VS) enables prioritization of AKR1C3 inhibitors by Longjiang Qiao, Xinyu Li, Shuaishuai Xing, Qianwen Guan, Kun Ning, Weijie Han, Luyu Zhang, Anlan Dai, Weiqi Yang, Yinhang Liu, Jason J Kwon, Xin Gao, Haopeng Sun, Yuemin Bian (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13631243.txt.
Description
Longjiang Qiao and thirteen colleagues built and stress-tested a machine learning pipeline for drug hunting. It targets one specific enzyme, AKR1C3. The enzyme helps cancers grow and resist chemotherapy. Their framework, called TAME-VS, expands sparse activity data using related enzymes. It then trains its classifiers. The study appeared in 2026.
The honest tests came in two waves. Looking back, the model faced inhibitor families it had never seen. It still prioritised well beyond simple similarity searching. Looking forward, its picks beat designer intuition under a tight synthesis budget. Two flagged compounds proved potent and selective. They restored sensitivity to a standard chemotherapy drug in resistant breast cancer cells. A public web server now runs the workflow.
Catalog record
| CREATOR | Longjiang Qiao, Xinyu Li, Shuaishuai Xing, Qianwen Guan, Kun Ning, Weijie Han, Luyu Zhang, Anlan Dai, Weiqi Yang, Yinhang Liu, Jason J Kwon, Xin Gao, Haopeng Sun, Yuemin Bian |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 87289 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |